|Articles|January 1, 2012
- Pharmaceutical Executive-01-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - January 2012
Industry Forecast 2012 : Bridging the Divide
Advertisement
Articles in this issue
about 14 years ago
Hungary Report: Redefining Sustainabilityabout 14 years ago
Emerging Markets: Bridging the Cancer Divideabout 14 years ago
Financing R&D Through a Range of Consumer Productsabout 14 years ago
New Year, New Issuesabout 14 years ago
Innovation: Why is Pharma Scared to Death?about 14 years ago
Top Medical Innovations 2012about 14 years ago
Essential Questions for Essential Benefitsabout 14 years ago
Copay Cards and Coupons: Letting the Facts Get in the Wayabout 14 years ago
Pharma 2012: Hard Times Before the Harvestabout 14 years ago
Here's to a Happier New Year?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
2
FDA Approves Yuvezzi to Treat Presbyopia in Adults
3
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
4
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
5